These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25753145)
1. GATA3 expression in gestational trophoblastic tissues and tumours. Mirkovic J; Elias K; Drapkin R; Barletta JA; Quade B; Hirsch MS Histopathology; 2015 Nov; 67(5):636-44. PubMed ID: 25753145 [TBL] [Abstract][Full Text] [Related]
2. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Banet N; Gown AM; Shih IeM; Kay Li Q; Roden RB; Nucci MR; Cheng L; Przybycin CG; Nasseri-Nik N; Wu LS; Netto GJ; Ronnett BM; Vang R Am J Surg Pathol; 2015 Jan; 39(1):101-8. PubMed ID: 25188865 [TBL] [Abstract][Full Text] [Related]
3. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions. Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843 [TBL] [Abstract][Full Text] [Related]
4. Analysis of PD-L1 expression in trophoblastic tissues and tumors. Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381 [TBL] [Abstract][Full Text] [Related]
8. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases. Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690 [TBL] [Abstract][Full Text] [Related]
9. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor. Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524 [TBL] [Abstract][Full Text] [Related]
10. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors. Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230 [TBL] [Abstract][Full Text] [Related]
12. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559 [TBL] [Abstract][Full Text] [Related]
13. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases. Veras E; Kurman RJ; Wang TL; Shih IM Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903 [TBL] [Abstract][Full Text] [Related]
14. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters. Xue WC; Khoo US; Ngan HY; Chan KY; Chiu PM; Tsao SW; Cheung AN Histopathology; 2003 Nov; 43(5):485-90. PubMed ID: 14636275 [TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the activating protein-1 family of transcription factors in gestational trophoblastic lesions. Briese J; Sudahl S; Schulte HM; Löning T; Bamberger AM Int J Gynecol Pathol; 2005 Jul; 24(3):265-70. PubMed ID: 15968203 [TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases. Barut A; Harma M; Arikan I; Harma MI; Barut F Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793 [TBL] [Abstract][Full Text] [Related]
17. A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Lee Y; Kim KR; McKeon F; Yang A; Boyd TK; Crum CP; Parast MM Hum Pathol; 2007 Jul; 38(7):1003-1013. PubMed ID: 17397906 [TBL] [Abstract][Full Text] [Related]
18. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328 [TBL] [Abstract][Full Text] [Related]
19. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656 [TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen and related molecules in normal and transformed trophoblast. Vićovac Lj; Bozić M; Bojić-Trbojević Z; Golubović S Placenta; 2007; 28(2-3):85-96. PubMed ID: 16574224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]